Abstract We found a low prevalence of SARS-CoV-2 (2.7% [5/188]) among pregnant and postpartum patients after initiating universal testing. Prevalence among symptomatic patients (22.2% [4/18]) was similar to initial targeted screening approaches (19.1% [8/42]). Among 170 asymptomatic patients, two were positive or inconclusive, respectively; repeat testing at 24 hours was negative.



Credit: iStock comzeal

Read more…


Citation: Sylvia M LaCourse, MD MPH, Alisa Kachikis, MD MSc, Michela Blain, MD, LaVone E Simmons, MD, James A Mays, MD, Amber D Pattison, RN-C, MSN, Carol C Salerno, MD, Stephen A McCartney, MD PhD, Nicole M Kretzer, MD PhD, Rebecca Resnick, PhD, Rosemary L Shay, MD, Leah M Savitsky, MD, Anna C Curtin, MD, Emily M Huebner, MSc, Kimberly K Ma, MD, Shani Delaney, MD, Carlos Delgado, MD, Adrienne Schippers, RN, BSN, Jeff Munson, PhD, Paul S Pottinger, MD, Seth Cohen, MD, Santiago Neme, MD MPH, Lori Bourassa, PhD MPH, Andrew Bryan, MD PhD, Alex Greninger, MD PhD MS MPhil, Keith R Jerome, MD PhD, Alison C Roxby, MD MSc, Erica Lokken, PhD MS, Edith Cheng, MD MS, Kristina M Adams Waldorf, MD, Jane Hitti, MD MPH MHA, Low prevalence of SARS-CoV-2 among pregnant and postpartum patients with universal screening in Seattle, Washington, Clinical Infectious Diseases, , ciaa675, https://doi.org/10.1093/cid/ciaa675